From Wikipedia, the free encyclopedia

Syncona (LSESYBC) is a large British closed-ended investment trust dedicated to life science investments. Established in October 2012 as Battle Against Cancer Investment Trust ('BACIT'), the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[1] Its chairman is Jeremy Tigue. The company has its own in-house management.[2]


  1. ^ "BACIT Changes Name To Syncona After Investment Shift". Morning Star. 19 December 2016. Retrieved 4 March 2017. 
  2. ^ "Annual Acoounts 31 March 2016" (PDF). BACIT. Retrieved 4 March 2014. 

External links

  • Official site
Retrieved from ""
This content was retrieved from Wikipedia :
This page is based on the copyrighted Wikipedia article "Syncona"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA